NEO
Price:
$16.04
Market Cap:
$2.06B
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
2004-03-16
Stock Exchange
NASDAQ
Ticker
NEO
According to NeoGenomics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 2.31B. This represents a change of 10.10% compared to the average of 2.10B of the last 4 quarters.
The mean historical Enterprise Value of NeoGenomics, Inc. over the last ten years is 2.04B. The current 2.31B Enterprise Value has changed 11.19% with respect to the historical average. Over the past ten years (40 quarters), NEO's Enterprise Value was at its highest in in the September 2021 quarter at 6.05B. The Enterprise Value was at its lowest in in the December 2014 quarter at 225.17M.
Average
2.04B
Median
1.38B
Minimum
197.82M
Maximum
5.84B
Discovering the peaks and valleys of NeoGenomics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 165.04%
Maximum Annual Enterprise Value = 5.84B
Minimum Annual Increase = -65.93%
Minimum Annual Enterprise Value = 197.82M
Year | Enterprise Value | Change |
---|---|---|
2023 | 2.30B | 53.78% |
2022 | 1.50B | -65.93% |
2021 | 4.39B | -24.79% |
2020 | 5.84B | 101.32% |
2019 | 2.90B | 130.57% |
2018 | 1.26B | 60.12% |
2017 | 785.14M | 4.15% |
2016 | 753.88M | 43.79% |
2015 | 524.30M | 165.04% |
2014 | 197.82M | 9.75% |
The current Enterprise Value of NeoGenomics, Inc. (NEO) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
2.73B
5-year avg
3.38B
10-year avg
2.04B
NeoGenomics, Inc.’s Enterprise Value is less than Natera, Inc. (13.60B), less than Qiagen N.V. (10.74B), less than Neogen Corporation (4.08B), less than Guardant Health, Inc. (3.23B), greater than CareDx, Inc (1.36B), less than Myriad Genetics, Inc. (2.57B), greater than Invitae Corporation (1.36B), greater than Castle Biosciences, Inc. (752.86M), less than Syneos Health, Inc. (7.27B), less than Mettler-Toledo International Inc. (31.35B), less than ICON Public Limited Company (28.13B), less than IQVIA Holdings Inc. (56.22B), less than Charles River Laboratories International, Inc. (12.37B), less than Sotera Health Company (6.53B), less than Olink Holding AB (publ) (3.16B), greater than Aclaris Therapeutics, Inc. (63.46M), greater than Twist Bioscience Corporation (2.00B), greater than Biodesix, Inc. (287.88M),
Company | Enterprise Value | Market cap |
---|---|---|
13.60B | $13.96B | |
10.74B | $9.87B | |
4.08B | $3.34B | |
3.23B | $2.92B | |
1.36B | $1.43B | |
2.57B | $2.45B | |
1.36B | $5.44M | |
752.86M | $813.24M | |
7.27B | $4.46B | |
31.35B | $29.36B | |
28.13B | $25.05B | |
56.22B | $44.31B | |
12.37B | $9.70B | |
6.53B | $4.43B | |
3.16B | $3.24B | |
63.46M | $83.47M | |
2.00B | $2.15B | |
287.88M | $268.58M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NeoGenomics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like NeoGenomics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is NeoGenomics, Inc.'s Enterprise Value?
What is the highest Enterprise Value for NeoGenomics, Inc. (NEO)?
What is the 3-year average Enterprise Value for NeoGenomics, Inc. (NEO)?
What is the 5-year average Enterprise Value for NeoGenomics, Inc. (NEO)?
How does the current Enterprise Value for NeoGenomics, Inc. (NEO) compare to its historical average?